Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury

David Plurad, Howard Belzberg, Ira Schulman, Donald Green, Ali Salim, Kenji Inaba, Peter M Rhee, Demetrios Demetriades

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Transfusions are known to be associated with Acute Respiratory Distress Syndrome (ARDS). Transfusion of leukoreduced products may be associated with a decreased incidence of late posttraumatic ARDS (late ARDS). Data from ventilated and transfused trauma patients were analyzed. Key variables in the first 48 hours of admission were studied for their associations with late ARDS and examined for changes over the 6 year study period. Late ARDS developed in 244 of the 1488 patients studied (16.4%). The incidence in patients given nonleukoreduced (NLR) product was 30.4 per cent (75/247) versus 13.6 per cent (169/1241) for patients not exposed [2.77 (2.02-3.73), P < 0.001]. Exposure to NLR products (50.9% in 2000 vs 1.9% in 2005) and incidence of ARDS (26.3% in 2000 vs 6.3% in 2005) significantly decreased. Treatment variables independently associated with late ARDS were NLR product exposure, Total Parenteral Nutrition exposure, Peak Inspiratory Pressure ≥ 30 mm Hg, fluid balance ≥ 2 liters at 48 hours, and transfusion of ≥ 10 units of any product. NLR product exposure has an association with an increased incidence of late onset posttraumatic ARDS which is independent of large volume transfusions. Leukoreduction should be routinely included in an overall treatment strategy to furthermore mitigate this complication in critically ill trauma patients.

Original languageEnglish (US)
Pages (from-to)117-123
Number of pages7
JournalAmerican Surgeon
Volume74
Issue number2
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Adult Respiratory Distress Syndrome
Incidence
Wounds and Injuries
Water-Electrolyte Balance
Total Parenteral Nutrition
Critical Illness
Pressure
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Plurad, D., Belzberg, H., Schulman, I., Green, D., Salim, A., Inaba, K., ... Demetriades, D. (2008). Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury. American Surgeon, 74(2), 117-123.

Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury. / Plurad, David; Belzberg, Howard; Schulman, Ira; Green, Donald; Salim, Ali; Inaba, Kenji; Rhee, Peter M; Demetriades, Demetrios.

In: American Surgeon, Vol. 74, No. 2, 02.2008, p. 117-123.

Research output: Contribution to journalArticle

Plurad, D, Belzberg, H, Schulman, I, Green, D, Salim, A, Inaba, K, Rhee, PM & Demetriades, D 2008, 'Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury', American Surgeon, vol. 74, no. 2, pp. 117-123.
Plurad D, Belzberg H, Schulman I, Green D, Salim A, Inaba K et al. Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury. American Surgeon. 2008 Feb;74(2):117-123.
Plurad, David ; Belzberg, Howard ; Schulman, Ira ; Green, Donald ; Salim, Ali ; Inaba, Kenji ; Rhee, Peter M ; Demetriades, Demetrios. / Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury. In: American Surgeon. 2008 ; Vol. 74, No. 2. pp. 117-123.
@article{1cb73048a7ec48eea3e55e4aca0b66fc,
title = "Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury",
abstract = "Transfusions are known to be associated with Acute Respiratory Distress Syndrome (ARDS). Transfusion of leukoreduced products may be associated with a decreased incidence of late posttraumatic ARDS (late ARDS). Data from ventilated and transfused trauma patients were analyzed. Key variables in the first 48 hours of admission were studied for their associations with late ARDS and examined for changes over the 6 year study period. Late ARDS developed in 244 of the 1488 patients studied (16.4{\%}). The incidence in patients given nonleukoreduced (NLR) product was 30.4 per cent (75/247) versus 13.6 per cent (169/1241) for patients not exposed [2.77 (2.02-3.73), P < 0.001]. Exposure to NLR products (50.9{\%} in 2000 vs 1.9{\%} in 2005) and incidence of ARDS (26.3{\%} in 2000 vs 6.3{\%} in 2005) significantly decreased. Treatment variables independently associated with late ARDS were NLR product exposure, Total Parenteral Nutrition exposure, Peak Inspiratory Pressure ≥ 30 mm Hg, fluid balance ≥ 2 liters at 48 hours, and transfusion of ≥ 10 units of any product. NLR product exposure has an association with an increased incidence of late onset posttraumatic ARDS which is independent of large volume transfusions. Leukoreduction should be routinely included in an overall treatment strategy to furthermore mitigate this complication in critically ill trauma patients.",
author = "David Plurad and Howard Belzberg and Ira Schulman and Donald Green and Ali Salim and Kenji Inaba and Rhee, {Peter M} and Demetrios Demetriades",
year = "2008",
month = "2",
language = "English (US)",
volume = "74",
pages = "117--123",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "2",

}

TY - JOUR

T1 - Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury

AU - Plurad, David

AU - Belzberg, Howard

AU - Schulman, Ira

AU - Green, Donald

AU - Salim, Ali

AU - Inaba, Kenji

AU - Rhee, Peter M

AU - Demetriades, Demetrios

PY - 2008/2

Y1 - 2008/2

N2 - Transfusions are known to be associated with Acute Respiratory Distress Syndrome (ARDS). Transfusion of leukoreduced products may be associated with a decreased incidence of late posttraumatic ARDS (late ARDS). Data from ventilated and transfused trauma patients were analyzed. Key variables in the first 48 hours of admission were studied for their associations with late ARDS and examined for changes over the 6 year study period. Late ARDS developed in 244 of the 1488 patients studied (16.4%). The incidence in patients given nonleukoreduced (NLR) product was 30.4 per cent (75/247) versus 13.6 per cent (169/1241) for patients not exposed [2.77 (2.02-3.73), P < 0.001]. Exposure to NLR products (50.9% in 2000 vs 1.9% in 2005) and incidence of ARDS (26.3% in 2000 vs 6.3% in 2005) significantly decreased. Treatment variables independently associated with late ARDS were NLR product exposure, Total Parenteral Nutrition exposure, Peak Inspiratory Pressure ≥ 30 mm Hg, fluid balance ≥ 2 liters at 48 hours, and transfusion of ≥ 10 units of any product. NLR product exposure has an association with an increased incidence of late onset posttraumatic ARDS which is independent of large volume transfusions. Leukoreduction should be routinely included in an overall treatment strategy to furthermore mitigate this complication in critically ill trauma patients.

AB - Transfusions are known to be associated with Acute Respiratory Distress Syndrome (ARDS). Transfusion of leukoreduced products may be associated with a decreased incidence of late posttraumatic ARDS (late ARDS). Data from ventilated and transfused trauma patients were analyzed. Key variables in the first 48 hours of admission were studied for their associations with late ARDS and examined for changes over the 6 year study period. Late ARDS developed in 244 of the 1488 patients studied (16.4%). The incidence in patients given nonleukoreduced (NLR) product was 30.4 per cent (75/247) versus 13.6 per cent (169/1241) for patients not exposed [2.77 (2.02-3.73), P < 0.001]. Exposure to NLR products (50.9% in 2000 vs 1.9% in 2005) and incidence of ARDS (26.3% in 2000 vs 6.3% in 2005) significantly decreased. Treatment variables independently associated with late ARDS were NLR product exposure, Total Parenteral Nutrition exposure, Peak Inspiratory Pressure ≥ 30 mm Hg, fluid balance ≥ 2 liters at 48 hours, and transfusion of ≥ 10 units of any product. NLR product exposure has an association with an increased incidence of late onset posttraumatic ARDS which is independent of large volume transfusions. Leukoreduction should be routinely included in an overall treatment strategy to furthermore mitigate this complication in critically ill trauma patients.

UR - http://www.scopus.com/inward/record.url?scp=40949156612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949156612&partnerID=8YFLogxK

M3 - Article

C2 - 18306860

AN - SCOPUS:40949156612

VL - 74

SP - 117

EP - 123

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 2

ER -